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ABSTRACT ‘‘TKO’’ is an expression vector that knocks
out the activity of a transcription factor in vivo under genetic
control. We describe a successful test of this concept that used
a sea urchin transcription factor of known function, P3A2, as
the target. The TKO cassette employs modular cis-regulatory
elements to express an encoded single-chain antibody that
prevents the P3A2 protein from binding DNA in vivo. In
normal development, one of the functions of the P3A2 tran-
scription factor is to repress directly the expression of the
CyIIIa cytoskeletal actin gene outside the aboral ectoderm of
the embryo. Ectopic expression in oral ectoderm occurs if
P3A2 sites are deleted from CyIIIa expression constructs, and
we show here that introduction of an aP3A2zTKO expression
cassette causes exactly the same ectopic oral expression of a
coinjected wild-type CyIIIa construct. Furthermore, the
aP3A2zTKO cassette derepresses the endogenous CyIIIa gene
in the oral ectoderm and in the endoderm. aP3A2zTKO thus
abrogates the function of the endogenous SpP3A2 transcrip-
tion factor with respect to spatial repression of the CyIIIa gene.
Widespread expression of aP3A2zTKO in the endoderm has
the additional lethal effect of disrupting morphogenesis of the
archenteron, revealing a previously unsuspected function of
SpP3A2 in endoderm development. In principle, TKO tech-
nology could be utilized for spatially and temporally con-
trolled blockade of any transcription factor in any biological
system amenable to gene transfer.
In this communication we describe a means of blocking a
specific gene regulatory interaction in living sea urchin em-
bryos. Sea urchins have a relatively simple process of embry-
ogenesis, and an efficient and straightforward method of gene
transfer has been developed, affording the opportunity to
introduce expression constructs into thousands of eggs per day.
Sea urchin eggs and embryos have thus emerged as a major
experimental system for analysis of developmental cis-
regulatory functions (1–3). Quantitative temporal and spatial
patterns of reporter-gene expression can be conveniently
assessed (e.g., refs. 3–5). Many relevant sea urchin transcrip-
tion factors have been purified by using affinity chromatog-
raphy after identification of their cis-regulatory target sites and
subsequently have been cloned (6). Antisense oligonucleotides
can be used to destroy maternal mRNAs encoding transcrip-
tion factors; however (7), there has been no general or direct
way to examine the function of specific transcription factors in
sea urchin embryos by blocking their activity in vivo. This
would afford the opportunity to compare the effects of can-
celing transcription factor activity with the effects of mutations
of the relevant target sites in an expression vector (8). More
generally, it would provide a means of determining down-
stream functions of the targeted factor.
Here we demonstrate the functional blockade of a tran-
scription factor that had previously been shown to be respon-
sible for spatial control of a developmentally regulated sea
urchin embryo gene. This was accomplished by introducing
into fertilized eggs an expression construct that encodes a
single-chain antibody that binds to the factor and prevents it
from forming complexes with its DNA target sites. We term
this a ‘‘TKO’’ (Transcription factor Knock Out) vector.
The TKO vector described herein was designed to attack the
SpP3A2 transcription factor (9), the initial member of a small
family of transcription factors that now includes Drosophila
erect wing (10), chicken IBRyF (11), and human NRF-1 (12).
P3A2 was cloned and characterized (9, 13) after identification
of two of its target sites in the cis-regulatory element of the
CyIIIa cytoskeletal actin gene, which were found to be re-
quired for correct spatial expression of this gene. This gene is
normally expressed only in aboral ectoderm lineages beginning
early in development. CyIIIazCAT expression constructs re-
produce the aboral expression of the parent gene, but if either
of the P3A2 sites in the wild-type construct is destroyed,
expression spreads dramatically to the oral ectoderm (14).
Similarly, if the endogenous P3A2 factor is titrated away from
the CyIIIazCAT expression construct by cointroduction of
excess target-site, ectopic oral ectoderm expression is also
observed (15). Our objectives in this work were threefold: first,
to develop a TKO vector that would effectively sequester
endogenous P3A2 transcription factor (aP3A2zTKO), the
functionality of which could be assayed by determining its
effects on spatial expression of CyIIIazCAT; second, to deter-
mine whether we could affect the expression of the endoge-
nous CyIIIa gene during embryonic development; and third, to
look for any other phenotypes in aP3A2zTKO embryos that
may indicate additional embryonic functions of the P3A2
transcription factor.
MATERIALS AND METHODS
DNA-Binding Inhibition Assays. P3A2 DNA-binding elec-
trophoretic mobility-shift assays (EMSAs) were performed as
previously described by Calzone et al. (9) using the P3A2
binding site (top strand: 59-GATCTTTTCGGCTTCTGCG-
CACACCCCACGCGCATGGGC-39) and crude nuclear ex-
tracts. Inhibition assays were performed by incubating P3A2
DNA binding reactions with serial dilutions of supernatant
from hybridoma-producing aP3A2 mAbs. The aP3A2 mAbs
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were created in the Caltech Monoclonal Antibody Facility
(16). Hybridoma ascites fluid and bacterial extracts containing
the aP3A2 sites were similarly assayed. In these assays, inhi-
bition of P3A2–DNA complex formation was estimated quan-
titatively as described in Fig. 1.
Production of the Single-Chain Anti-P3A2 Antibody. Hy-
bridoma poly(A) RNA was purified by using the Stratagene
RNA Isolation kit and Dynal (Great Neck, NY) oligo(dT)
beads as described by the manufacturers. Heavy- and light-
chain cDNAs were isolated from hybridoma cDNA libraries
constructed by using the Stratagene Uni-Zap vector system.
Subsequently, the variable heavy- and light-chain coding re-
gions of these cDNAs were fused in-frame (separated by an
encoded flexible GlyySer linker) into the pCANTAB 5 vector
by using the expression module of the Pharmacia single-chain
antibody (scFv) system.
Construction of TKO and Green Fluorescent Protein (GFP)
Expression Cassettes. The TKO cassette was constructed in
steps. First, the simian virus (SV)40 large T 39 untranslated
intron, transcriptional attenuation, and polyadenylation sig-
nals isolated from the pNL vector (17) were cloned into the
EcoRI site of pBluescript II KS2 [BSpoly(A) construct].
Second, the coding region of the aP3A2 scFv was recovered
from the positive pCANTAB 5 phagemid by PCR, using either
the Ab1 59 primer to make the TKO expression cassette or the
Ab3 59 primer to make a missense control cassette. Primers
were as follows: Ab1, 59-GGGCGGCCGCCACCATGGCC-
ACCGCCCCAAAGAAGAAGCGTAAGGCCCAGGTGA-
AACTGCAG-39. The italicized base is deleted in primer Ab3
59; otherwise, primers Ab1 59 and Ab3 59 are identical.
Sequences encoding a nuclear localization site following the
ATG site: Ab-reverse, 59-GGGACTAGTCTTGTCGTCGT-
CGTCCTTGTAGTCCACCGGCGCACCTGCGGC-39.
Standard PCR was carried out in 100-ml volumes containing 50
pmol of each primer, 13 Deep Vent buffer (New England
Biolabs), 2 mmol of dNTPs, '10 ng of target sequence, and
sterile H2O. Reactions were heated to 94°C for 2 min, 5 units
of Deep Vent polymerase was added (New England Biolabs),
and the mixture was cycled 25 times (30 sec, 94°C; 30 sec, 60°C;
60 sec, 72°C) in a Perkin–Elmer 9600 thermocycler. The PCR
products were digested with NotI, purified, and ligated into the
BSpoly(A)1 vector. The final TKO and missense cassettes were
made by ligating either the cis-regulatory element (18) of the
SpH2b early histone gene into the SacII site or the SpHE
hatching enzyme gene cis-regulatory element (a gift from L.
Angerer, University of Rochester, Rochester, NY; see ref. 19)
into the SacI site of the respective TKO and missense con-
structs. The histone gene regulatory sequences were amplified
from the SpH2b clone (18) with the following oligonucleotide
primers: H2b5, 59-CCCGCGGCCGCGGTCTCAAAATATG-
ATTGGCAGCTTAATTTGG-39 and H2b3, 59-CCCCCGCG-
GGATGATTGTGATTCTCACGAATGC-39. The hatching
enzyme gene regulatory sequence was amplified from the
parent SpHE-pNL clone by using HE5: 59-CCCCCGCGGA-
AGCTTGTTTTGATTGGTTTGTTTGG-39 and HE3: 59-C-
CCCCGCGGGATGATAAGAAGTGATAATGATTTTC-39.
The pCANTAB5 anti-P3A2 scFv and TKO inserts were
sequenced in an Applied Biosystems 373 sequencer. TKO and
aP3A2zTKOmis (missense) plasmids were linearized with ClaI
for microinjection. A pHEyGFP expression vector was con-
structed by amplifying the SpHE regulatory element with
primers HESI5, 59-CCCGAGCTCAAGCTTGTTTTGATTG-
GTTTGTTTGG-39 and HE3, 59-CCCGAGCTCGATGATAA-
GAAGTGATAATGATTTTC-39 and ligating the product into
the GFP expression vector pGL3-Basic (5). The resulting plasmid
was linearized with KpnI for microinjection.
Microinjection, Whole-Mount in Situ Hybridization, and
Fluorescence Microscopy. Microinjection and culture of
Strongylocentrotus purpuratus embryos were performed essen-
tially as described (14). However, when multiple constructs
were coinjected, we maintained the total amount of DNA
injected at a constant level by proportionately lowering the
amount of carrier DNA. Detection of endogenous CyIIIa
expression by whole-mount in situ hybridization (WMISH) was
carried out following the protocol of Ransick et al. (24) with
the following modifications: The fixation step was lengthened
to 20 min and the probe concentration was raised to 0.4 ngyml.
The CyIIIa antisense probe was generated by in vitro tran-
scription from the T7 promoter of the CyIIIa–HgaI vector that
had been digested with PvuII. This generates a digoxigenin-
labeled probe containing 147 bases of the CyIIIa, 39 untrans-
lated region, and an 873-bp tail of pBluescript II SK2 (pro-
cedure of David G.-W.Wang, personal communication). Flu-
orescence microscopy, sorting, and WMISH of GFP-injected
embryos were performed as described (5).
RESULTS
aP3A2 mAb and aP3A2zTKO Construct. The TKO expres-
sion construct was designed to express, translate, and transport
an anti-P3A2 reagent into the nucleus so as to inhibit P3A2
from carrying out its developmental regulatory functions in
vivo. A set of aP3A2 mAbs was generated against the full-
length P3A2 protein. These were screened for their ability to
inhibit this protein from binding to its target DNA sequence
by adding them to gel-shift reactions at increasing dilutions.
Inhibitory activity was measured quantitatively as described in
Fig. 1. Inhibition constants were determined for 12 different
hybridoma subclones. mAb 7B12y2E7 displayed the strongest
inhibitory effects on P3A2 DNA binding and was chosen as the
FIG. 1. Measurement of inhibitory activity of mAb with respect to
specific P3A2–DNA complex formation. Relative occupancy of oli-
gonucleotide probe (Y) is plotted against an antibody dilution series
(A). The intercept, Y0 (here Y0 5 0.78 of total probe in the reaction)
represents the probe occupancy in the absence of antibody (A 5 0).
The inhibitory activity is quantitatively estimated as the value of kA,
the slope; here, kA 5 1.26 3 1010 M21. The data are fit to the function
Y 5 akAzA 1 Y0 (Eq. 1). Here Y is occupancy of oligonucleotide probe;
i.e., where PD(A) dilution (antibody concentration was measured after
purification of the antibody from the hybridoma ascites fluid) and D0
is concentration of total probe in the reaction: Y 5 PDAyD0. In Eq. 1,
a 5 22P0, where P0 is the molar quantity of P3A2 transcription factor
in the reaction; in these experiments, P0 ranged from 2 to 5 3 10211
M. kA is defined as the equilibrium constant for the reaction of a mAb
molecule with two P3A2 molecules, i.e., kA 5 AP2yA z P02. Eq. (1)
follows from the assumption that all P3A2 molecules will be in
complex with either the antibody or the DNA probe and that the
P3A2–DNA reaction is bimolecular, i.e., PD(A) 5 kDP(A) z D(A), where
P(A) and D(A) are the molar concentrations of the free P3A2 protein
and the DNA probe at given antibody dilutions.
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basis for the aP3A2zTKO vector. The same mAb was used for
an extensive series of measurements of P3A2 prevalence
throughout embryological development (16). The specificity of
this antibody was confirmed by the observation that it reacted
with only a single molecular species of the known size of the
P3A2 transcription factor in total nuclear extracts from all
stages of development as well as in total egg lysate (Fig. 1 of
ref. 16).
To build the aP3A2zTKO vector, the mRNA was extracted
from 7B12y2E7 hybridoma cells, and by using the universal
IgG primers amplified DNAs encoding the heavy-chain and
light-chain V-regions were cloned in-frame into the Pharmacia
pCANTAB vector surrounding a flexible GlyySer linker. Thus,
a construct encoding a single-chain antibody was produced.
Gel-shift inhibition assays were repeated to test the inhibitory
activity of the aP3A2 scFv, which was extracted for this
purpose from bacteria expressing the pCANTAB vector. Its
activity was found to be quantitatively equivalent to that of the
starting mAb. As described in Materials and Methods, the
aP3A2 scFv was then incorporated into an expression cassette,
the organization of which is summarized in Fig. 2. In addition
to the scFv itself, the major features of the aP3A2zTKO
construct are: (i) a nuclear localization site intended to in-
crease the concentration of the scFv in the nucleus relative to
that of the endogenous nuclear P3A2 factor; (ii) simian virus
(SV)40 intron, 39 trailer, termination, and poly(A) addition
sites, features that are conventionally used in most sea urchin
gene-transfer vectors; and (iii) a cis-regulatory control ele-
ment. This last design feature, in principle, permits expression
of the TKO vector to be targeted to any domain of the embryo
for which a cis-regulatory element is available. However, in the
present experiments we utilized instead ubiquitously, or nearly
ubiquitously, active cis-regulatory elements derived from a
histone H2b gene (18) and from a hatching enzyme gene (19).
Stable incorporation of exogenous DNA in sea urchin embryo
blastomeres is mosaic, although entirely random with respect
to lineage (20), and therefore embryos are obtained that have
incorporated the exogenous DNA into every possible spatial
domain. In some of the experiments that follow, the
aP3A2zTKO vector was coinjected with a GFP reporter under
control of the same cis-regulatory element, so that the partic-
ular cells incorporating the aP3A2zTKO construct could be
identified visually by GFP expression following the procedures
of Arnone et al. (5). Thus, we could examine embryos in which
the construct was present in endoderm, aboral ectoderm, or
oral ectoderm, as desired.
aP3A2zTKO Effects on Spatial Expression of a Wild-Type
CyIIIazCAT Construct. When CyIIIazCAT constructs lacking
the two known P3A2 target sites are injected into eggs, ectopic
oral ectoderm expression is observed in an average of 34% of
stained embryos (14). Because this is statistically equivalent to
the percentage of embryos that incorporate exogenous DNA
into oral ectoderm founder cells, it follows that essentially all
oral ectoderm cells will express the CyIIIazCAT construct if
interactions with the P3A2 repressor are obviated by deletion.
In the CyIIIazCAT experiments summarized in Table 1,
aP3A2zTKO or a missense frame shift control differing from
aP3A2zTKO by deletion of only 1 bp were coinjected with
wild-type CyIIIazCAT (14). Wild-type CyIIIazCAT and
DP3A2zHF, the CyIIIazCAT construct lacking the two P3A2
sites, were injected at the same time as the TKO constructs and
performed as reported (14). When coinjected with wild-type
CyIIIazCAT, the missense aP3A2zTKO had no effect (2% oral
expression). However, a remarkable result was obtained when
wild-type CyIIIazCAT was coinjected with aP3A2zTKO: 26% of
stained embryos now displayed oral ectoderm expression, as
illustrated in the example reproduced in Fig. 3 c and d. The
26% value could represent a slight underestimate of
aP3A2zTKO effects or CyIIIazCAT expression because in these
experiments only morphologically normal stained embryos
were counted, and as we discuss below, a significant fraction
of embryos receiving aP3A2zTKO develop abnormally. In any
case, the results are those predicted if the aP3A2zTKO vector
effectively sequesters the endogenous P3A2 factor, thus pre-
venting its interaction with the CyIIIazCAT regulatory target
sites. That is, as Table 1 shows, the fraction of ectopically
expressing embryos is about the same as when P3A2–
CyIIIazCAT interactions are instead prevented by deletion of
these target sites.
We note here that coinjection of the anti-P3A2 antibody
protein into eggs together with CyIIIazCAT also led to ectopic
oral expression of the CyIIIazCAT reporter (C. Kirchhamer
and E.H.D., unpublished results). These effects were not
observed when an irrelevant antibody was injected. However,
this approach can be applied only to early embryos; further-
more, the aP3A2 and the control IgG caused lethal arrest of
development in an unacceptably large fraction of embryos.
aP3A2zTKO Effects on Spatial Expression of the Endoge-
nous CyIIIa Gene. The foregoing results confirm the role of the
P3A2 transcription factor as a spatial repressor of CyIIIazCAT
expression and raise the question whether the endogenous
gene could be similarly affected by aP3A2zTKO. This was not
obvious a priori, because we had found earlier that the stability
of endogenous CyIIIa regulatory complexes exceeds that of the
equivalent CyIIIazCAT complexes: thus, in vivo competition
with excess target sites for a number of CyIIIa factors stoi-
chiometrically reduced expression of exogenous CyIIIazCAT,
whereas expression of the endogenous CyIIIa gene was unaf-
fected in the same embryos (22).
The normal aboral ectoderm expression of the endogenous
CyIIIa gene is displayed by WMISH in Fig. 3 a and b. When
eggs were injected with aP3A2zTKO and endogenous CyIIIa
expression was similarly monitored, ectopic expression of the
FIG. 2. The TKO expression cassette. Histone 2b or hatching
enzyme cis-regulatory elements (A) employed in the cassette are
modular and can easily be exchanged with any other regulatory
sequence. The start of transcription (B) is set to be at least 20 bp
upstream of a canonical Kozak ATG (C) and a nuclear localization
sequence (D) that are best fit to sea urchin initiators and codon usage.
The heavy- (E) and light-chain (G) variable regions of the anti-P3A2
scFv are separated by an encoded flexible GlyySer linker (F). To
process, stabilize, and terminate the TKO transcripts, we inserted the
SV40 large T 39 intron (I), polyadenylation (J), and transcriptional
termination (K) sequences after the stop codon (H).
Table 1. Effect of aP3A2zTKO and control constructs on
CyIIIazCAT and CyIIIa expression
Construct
48-hr
embryo
no. tested*
Ectopic
mRNA
in oral
ectoderm, %
mRNA
in aboral
ectoderm, %
CyIIIa CAT CyIIIa CAT
CyIIIazCAT†
(wild type) 531 — 3.2 — 96
DP3A2zHF† 192 — 34 — 95
aP3A2zTKO 108 — 26 — 83
aP3A2zTKOmis 184 — 2 — 99
aP3A2zTKO 70 27 — 100 —
aP3A2zTKOmis 35 8 — 100 —
*Data are reproduced for interpretably stained embryos (60–901 of all
those injected in ref. 14 and this study).
†Data reproduced from Kirchhamer and Davidson (14) for compar-
ison.
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endogenous gene was observed. As summarized in Table 1,
27% of these embryos display clear expression in clones of oral
ectoderm, and frequently in limited clones of gut cells as well.
Examples are reproduced in Fig. 3 e and f. Three embryos that
displayed ectopic expression in the missense control were also
found (Table 1). Because the endogenous CyIIIa gene is never
expressed erroneously, the single base mutation that distin-
guishes aP3A2zTKOmis from aP3A2zTKO might not have
entirely prevented synthesis of a functional TKO product. For
example, a partially functional protein might have been gen-
erated by use of a downstream ATG. In any case, the percent-
age of ectopic oral expression observed in the aP3A2zTKO
sample is very similar to that seen with either the mutated
CyIIIa reporter lacking P3A2 sites (14) or in the coinjections
of aP3A2zTKO and wild-type CyIIIa reporters (Table 1). This
is as expected, because ectopic oral expression depends on
clonal incorporation of the aP3A2zTKO construct in oral
ectoderm cells in all three experiments.
A Specific aP3A2zTKO Embryonic Phenotype. Embryos
developing from eggs injected with aP3A2zTKO display a
specific lethal phenotype. This occurs in a relatively high
fraction of embryos, 44% in the experiment tabulated in Table
2, although in other experiments somewhat more modest
frequencies of 20–30% were recorded. The aP3A2zTKOmis
control resulted in only 5% abnormal embryos (Table 2). This
phenotype is best described as a failure to form a complete
archenteron, caused by a disorganization of the endoderm. Fig.
3g shows a normal 72-hr prism-stage embryo that developed
from an egg that had been injected with the missense control
construct, whereas the embryo in Fig. 3h displays the
FIG. 3. Effects of aP3A2zTKO on expression of CyIIIazCAT, endogenous CyIIIa, and the lethal embryonic phenotype. In a–f, the H2b
cis-regulatory element was used to drive expression of the injected TKO constructs, and in g–l, the hatching enzyme cis-regulatory element was
used (see Materials and Methods). (a, b) Endogenous CyIIIa expression monitored by WMISH using an antisense CyIIIa probe (see Materials and
Methods). (a) Embryo viewed laterally, oral side to the right; here and in following panels the arrows bracket the oral ectoderm where neither CyIIIa
nor wild-type CyIIIazCAT expression occurs. (b) Anal view, oral side to the top. (c, d) CyIIIazCAT coinjected with aP3A2zTKO, driven by the H2b
cis-regulatory element, lateral views. Clones of cells expressing CAT mRNA in the oral ectoderm are displayed by using WMISH. As observed
when the P3A2 sites are deleted (14), these injections produce embryos displaying normal patterns of aboral ectoderm expression (i.e., embryos
in which the exogenous DNA resides in the aboral ectoderm); embryos displaying both normal and ectopic oral ectoderm expression; and embryos
displaying oral expression only (i.e., the exogenous DNA is only in oral ectoderm lineages); only the latter are illustrated here. (e, f ) Effects of
aP3A2zTKO on endogenous CyIIIa gene expression, monitored as in a and b. Both embryos are shown from the blastopore, and both display ectopic
oral staining as well as staining in clones of archenteron cells in addition to aboral ectoderm expression. (g) Pluteus-stage (72-hr) embryo viewed
from anal side. This embryo bears the aP3A2zTKOmis construct and is normal in morphology. (h) Gastrulation-defective phenotype at 72 hr caused
by injection of the aP3A2zTKO construct. (i) Gastrulation-defective embryo at 48 hr viewed from blastopore, in which Endo16 transcripts are
displayed by using WMISH. (j) Normal 48-hr embryo viewed laterally and bearing GFP-expressing clones of exogenous DNA in aboral ectoderm
and archenteron. These clones also include the aP3A2zTKOmis control construct. (k, l) Gastrulation-defective embryos as in j, but bearing
aP3A2zTKO construct present in large endodermal clones.
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aP3A2zTKO phenotype. This embryo has not completed gas-
trulation. Its endoderm consists of a pile of nonadherent cells,
and the form of the embryo is round rather than triangular.
The secondary mesoderm appears unaffected, however. Such
embryos appear to develop normally up to gastrulation. The
implication is that P3A2 transcription factor is necessary for
morphogenesis of the archenteron, a previously unknown
function.
To further investigate the role of the P3A2 transcription
factor in archenteron formation, we performed a series of
coinjection experiments making use of GFP as a marker to
determine location of the aP3A2zTKO construct in the exper-
imental embryos. GFP expression constructs can be used to
determine the mosaic expression domain of a coinjected
construct if both constructs are driven by the same cis-
regulatory elements, because shortly after injection the exog-
enous DNAs are all ligated together into a concatenate and are
then incorporated into the same blastomeres (5). In these
experiments, the hatching enzyme cis-regulatory element was
used to drive both the GFP and aP3A2zTKO constructs.
Results are listed in Table 3. Significantly, all of the embryos
bearing aP3A2zTKO that failed to gastrulate express the GFP
marker in the endoderm (89 of 89), and less than 10% of the
set of embryos in which GFP is expressed in the endoderm
develop normally. All of those that do are distinguished by
small GFP clone sizes (not shown). On the other hand, most
of the 48% of the embryos injected with the missense control
that contained endodermal clones developed normally, even
though these clones were often quite large. An example is
shown in Fig. 3j. Embryos bearing aP3A2zTKO that failed to
gastrulate and that contained the exogenous DNA in the
endoderm are illustrated in Fig. 3 k and l. The disorganized
endoderm cells in these embryos retain their endodermal state
of specification; that is, they continue to express the Endo16
marker (2, 23, 24), as shown, for example, in Fig. 3i. A few
embryos in the missense control experiment also showed
gastrulation defects (Table 3), and all of these contained large
endodermal clones. This result again supports a weak expres-
sion of an aP3A2zTKO activity because of override of the
frameshift, as considered above.
To explore further the relation between location of clonal
incorporation and occurrence of the gastrulation phenotype,
we carried out the experiment summarized in Table 4. Em-
bryos bearing aP3A2zTKO plus GFP constructs were sorted
according to the locus of incorporation of the expression
constructs, and CyIIIa expression was then monitored by
WMISH in the sorted samples. Table 4 shows that the locus of
incorporation correlates perfectly with the effect of
aP3A2zTKO on CyIIIa expression. All embryos selected for
large endoderm clones again were gastrulation-defective (19 of
19), whereas 9 of 10 embryos that contained large oral-
ectoderm clones displayed ectopic expression of CyIIIa in the
oral ectoderm. Conversely, all embryos bearing large aboral
ectoderm clones displayed normal CyIIIa expression.
It may be concluded from these experiments that the
function of P3A2 in archenteron morphogenesis is cell-
autonomous, i.e., that the factor is needed in the archenteron
cells themselves. Similarly, we confirm that the function of
P3A2 in oral ectoderm as a spatial repressor of CyIIIa tran-
scription is also autonomous, as proposed earlier (14).
DISCUSSION
We describe here the use of a genetic expression vector that
abrogates the activity of a transcription factor in a living
embryo. Three main results were obtained. First, the intracel-
lular efficacy of a scFv for this purpose was established by
demonstration of the same ectopic expression of the
CyIIIazCAT vector as is caused by deletion of the target sites
for this transcription factor. Second, we confirmed that the
P3A2 factor indeed serves as a spatial repressor for the CyIIIa
gene and extend this observation from CyIIIazCAT expression
constructs to the endogenous CyIIIa gene. Third, we discov-
ered a hitherto unknown function of P3A2 in archenteron
morphogenesis. Both this function and the effects of the P3A2
factor on CyIIIa expression are cell autonomous.
It is striking that CyIIIazCAT and CyIIIa gene expression are
so efficiently expanded to the oral ectoderm in embryos
bearing aP3A2zTKO in oral ectoderm clones. P3A2 is initially
a relatively prevalent maternal factor, present in about 2 3 106
molecules per embryo (16) and is later zygotically transcribed;
there are a few thousand to a few hundred molecules per
nucleus throughout development (16, 25). The affinity of the
scFv encoded by the aP3A2zTKO vector for the P3A2 factor is
significantly higher than that of the factor for its DNA target
site (9, 13) as calculated from experiments such as that shown
in Fig. 1. Thus, the scFv apparently acts as a very effective
intracellular sequestering agent. Nor is any nonspecific early
embryonic lethality observed, in contrast to the general del-
eterious effect of injecting the mAb per se into eggs (unpub-
lished results). Furthermore, use of a genetic vehicle for
producing the aP3A2 scFv ensures that it will continue to
function through development (depending of course on the
cis-regulatory element driving its expression), which is never
reliably the case for either protein or mRNA introduced
directly into the egg. The results shown in this paper confirm
that aP3A2zTKO continues to function through embryogenesis
(Fig. 3).
An unexpected aspect of the spatial derepression of the
endogenous CyIIIa gene caused by introduction of aP3A2zTKO
is that ectopic expression was observed not only in oral
ectoderm but also in gut (Fig. 3 e and f ). Recent studies (ref.
14, and earlier observations reviewed therein) proved that the
two P3A2 sites deleted in the experiments of Kirchhamer and
Davidson (14) are required to prevent ectopic oral-ectoderm
expression of CyIIIazCAT constructs, but no ectopic gut ex-
pression was observed in these experiments. However, there
are additional potential P3A2 sites in the CyIIIa cis-regulatory
element, and these may be responsible for controlling expres-
sion in gut.
Table 2. aP3A2zTKO effect on embryo development
Construct
Embryos,
no. tested
Gastrulation-
defective, %
aP3A2zTKO 419 44
aP3A2zTKOmis 345 5
Table 3. Expression of GFP in aP3A2zTKO and
a3PA2zTKOmis embryos
Construct Phenotype
Embryos,
no. tested
Endomeso-
derm, %
Ectoderm,
%
aP3A2zTKO Normal 77 9 95
aP3A2zTKO GD 89 100 73
aP3A2zTKOmis Normal 186 48 78
aP3A2zTKOmis GD 15 100 73
GD, gastrulation defective.
Table 4. CyIIIa transcripts in presorted embryos bearing GFP and
TKO (aP3A2zTKO) expression constructs
Phenotype GFP sorted Endomesoderm Oral Aboral
GD Endoderm 19y19 ND ND
Normal Oral 0 9y10 10y10
Normal Aboral 0 0 9y9
GD, gastrulation-defective; ND, not done. Oral and aboral ecto-
dermal domains are difficult to distinguish in gastrulation-defective
embryos, because of their abnormally rounded form (see Fig. 3h, for
example).
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A new role for P3A2 in archenteron formation was revealed
when we examined the postgastrular lethal phenotype pro-
duced by aP3A2zTKO injection into fertilized eggs. This effect
occurs only when the construct is present in large clones of
archenteron cells. These cells fail to adhere to one another so
that the archenteron disintegrates into a wholly or partially
disorganized pile of endoderm cells. Yet these cells retain their
state of specification, as monitored by expression of an
endoderm-specific gene, Endo16. The implication is that genes
encoding some cell surface proteins are controlled by P3A2
either directly or indirectly. If directly, it is possible that P3A2
acts positively in this context, although its function is clearly
negative in regulation of the CyIIIa gene.
There are many obvious possible extensions of the TKO
technology described here, both in research and potentially for
gene therapy (26). We are now extending the TKO approach
to several other sea urchin embryo transcription factors. This
may become a general method for examination of trans-
regulatory functions. One powerful potential advantage of the
TKO method is the possibility of exactly controlling the time
and place of TKO expression. This depends directly on the
cis-regulatory system employed to drive the transcription of
the TKO vector. Thus, for example, TKO vectors could be built
and inserted into the mouse genome that would blockade given
transcription factors only in given cell types at given stages of
development. This could provide a decisive advantage given
that transcription factors are often utilized at many stages of
the life cycle and used for many diverse developmental pur-
poses.
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